News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Teva Pharmaceutical Industries Limited (TEVA) Drug Halved Risk of Full-Blown Multiple Sclerosis in Vita-Salute University Study


10/7/2009 6:49:47 AM

Bookmark and Share

Oct. 7 (Bloomberg) -- Teva Pharmaceutical Industries Ltd.’s Copaxone drug can cut the likelihood of patients progressing to full-blown multiple sclerosis almost in half, researchers said.

Read at Bloomberg
Read at AFP
Read at HealthDay

comments powered by Disqus
Bloomberg
AFP
HealthDay
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES